Clinical Trial Update: Neural and Behavioral Effects of Oxytocin in Autism Spectrum Disorders [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating neural and behavioral effects of oxytocin in autism spectrum disorders has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Autism Spectrum Disorder

Drugs mentioned

• Oxytocin (Oxytocin)

Snippet

Sponsor: KU Leuven | Conditions: Autism Spectrum Disorders | Phase 4 | Status: COMPLETED | Results posted: 2020-02-13